SCHEMBL9834640

SCHEMBL9834640

C=CCC1C(=O)Nc2cc3[nH]c(C)nc3cc21

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
ALDH1A1 P00352 3/20 0.38
POLB P06746 3/20 0.33
HPGD P15428 2/20 0.33
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
HSP90AA1 P07900 1/20 0.33
ESR2 Q92731 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PDE1A P54750 1/20 0.32
PDE1B Q01064 1/20 0.32
PDE1C Q14123 1/20 0.32
ADAMTS5 Q9UNA0 1/20 0.31
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10666126 0.82 ADAMTS5 (0.41) CHRNB2CHRNA4ALDH1A1POLBHPGD
SCHEMBL9834478 0.81 CHRNB2 (0.40) CHRNB2CHRNA4ALDH1A1POLBHPGD
SCHEMBL9833204 0.79 RHEB (0.47) ALDH1A1POLBHPGDMAPTKDM4E
SCHEMBL10666088 0.79 CHRNB2 (0.39) CHRNB2CHRNA4ALDH1A1POLBHPGD
SCHEMBL9835975 0.77 CHRNB2 (0.46) CHRNB2CHRNA4ALDH1A1POLBHPGD
SCHEMBL10473663 0.76 MAPT (0.50) ALDH1A1POLBHPGDMAPTKDM4E
SCHEMBL9833698 0.76 PGR (0.36) MAPTTDP1ADAMTS5TP53
SCHEMBL9835021 0.74 CHRNB2 (0.43) CHRNB2CHRNA4ALDH1A1POLBHPGD
SCHEMBL9833431 0.73 CHRNB2 (0.40) CHRNB2CHRNA4ALDH1A1POLBHPGD
SCHEMBL9832544 0.73 CHRNB2 (0.42) CHRNB2CHRNA4ALDH1A1POLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0214592-B1 PYRROLOBENZIMIDAZOLES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE PRODUCTS Roche Diagnostics GmbH (DE) 1991-08-14 EP disclosed
US-4730003-A Tricyclic compounds for treating heart and circulatory diseases BOEHRINGER MANNHEIM GMBH (DE) 1988-03-08 US disclosed
EP-0214592-A2 Pyrrolobenzimidazoles, process for their preparation and medicaments containing these products Roche Diagnostics GmbH (DE) 1987-03-18 EP disclosed